Both in Pharmaceuticals
Nektar Therapeutics vs Kardigan
Over the past year NKTR returned −45.7% and KARD returned −24.0%; their daily moves had a correlation of 0.30.
NKTR −45.7% KARD −24.0%Growth of $1, one year, split-adjusted
| Metric | NKTR | KARD |
|---|---|---|
| Price | $37.89 | $14.07 |
| Market cap | $1.29B | $1.32B |
| Today | +2.54% | −0.99% |
| 1 month | −10.3% | −7.7% |
| 6 months | −55.0% | — |
| Year to date | −10.4% | — |
| 1 year | −41.6% | — |
| Revenue growth (YoY) | −9.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −401.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 23.7× | — |
| Net cash | $684.3M | $597.6M |
| Dividend yield | — | — |
| Volatility (60d) | 70.0% | — |
| Short % of float | 21.0% | 13.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).